Robert L. Ludwig

6.1k total citations · 3 hit papers
20 papers, 4.1k citations indexed

About

Robert L. Ludwig is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Robert L. Ludwig has authored 20 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Robert L. Ludwig's work include Cancer-related Molecular Pathways (16 papers), Ubiquitin and proteasome pathways (10 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Robert L. Ludwig is often cited by papers focused on Cancer-related Molecular Pathways (16 papers), Ubiquitin and proteasome pathways (10 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Robert L. Ludwig collaborates with scholars based in United States, United Kingdom and Germany. Robert L. Ludwig's co-authors include Karen H. Vousden, Jane P. Jensen, Allan M. Weissman, Shengyun Fang, Michael H.G. Kubbutat, Marion Lohrum, Mary H. Hanlon, Stewart Bates, Margaret Ashcroft and Douglas Woods and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Robert L. Ludwig

20 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53

2000 874 citations Shengyun Fang, Jane P. Jensen et al. Journal of Biological Chemistry profile →
Mutant p53 Drives Invasion by Promoting Integrin Recycling

2009 641 citations Patricia Müller, Patrick T. Caswell et al. Cell profile →
Regulation of HDM2 activity by the ribosomal protein L11

2003 521 citations Marion Lohrum, Robert L. Ludwig et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert L. Ludwig United States	18	3.3k	2.4k	693	562	452	20	4.1k
Mark K. Saville United Kingdom	23	2.7k 0.8×	1.9k 0.8×	490 0.7×	362 0.6×	267 0.6×	33	3.2k
Carol Midgley United Kingdom	27	3.5k 1.1×	3.0k 1.3×	597 0.9×	419 0.7×	824 1.8×	32	4.8k
Anne M. Theodoras United States	8	2.5k 0.8×	2.1k 0.9×	399 0.6×	622 1.1×	186 0.4×	8	3.2k
Brian Elenbaas United States	17	2.8k 0.9×	2.4k 1.0×	640 0.9×	331 0.6×	524 1.2×	26	4.1k
Aart G. Jochemsen Netherlands	26	3.0k 0.9×	3.0k 1.2×	545 0.8×	365 0.6×	658 1.5×	37	3.7k
Dalia Resnitzky Israel	18	2.7k 0.8×	2.3k 1.0×	410 0.6×	753 1.3×	249 0.6×	21	3.8k
Brigitte M. Pützer Germany	41	2.9k 0.9×	1.9k 0.8×	905 1.3×	256 0.5×	503 1.1×	112	4.3k
Aart G. Jochemsen Netherlands	34	2.8k 0.8×	2.0k 0.8×	483 0.7×	368 0.7×	406 0.9×	70	3.7k
Eros Lazzerini Denchi United States	29	4.7k 1.4×	1.5k 0.6×	568 0.8×	495 0.9×	217 0.5×	45	5.7k
David Dornan United States	20	2.5k 0.8×	1.4k 0.6×	816 1.2×	281 0.5×	167 0.4×	38	3.1k

Countries citing papers authored by Robert L. Ludwig

Since Specialization

Citations

This map shows the geographic impact of Robert L. Ludwig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Ludwig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Ludwig more than expected).

Fields of papers citing papers by Robert L. Ludwig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Ludwig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Ludwig. The network helps show where Robert L. Ludwig may publish in the future.

Co-authorship network of co-authors of Robert L. Ludwig

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Ludwig. A scholar is included among the top collaborators of Robert L. Ludwig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Ludwig. Robert L. Ludwig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheung, Eric C., Robert L. Ludwig, & Karen H. Vousden. (2012). Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death. Proceedings of the National Academy of Sciences. 109(50). 20491–20496. 186 indexed citations

Hock, Andreas, et al.. (2011). Regulation of p53 stability and function by the deubiquitinating enzyme USP42. The EMBO Journal. 30(24). 4921–4930. 91 indexed citations

Vigneron, Arnaud, Robert L. Ludwig, & Karen H. Vousden. (2010). Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP. Genes & Development. 24(21). 2430–2439. 90 indexed citations

Müller, Patricia, Patrick T. Caswell, Brendan Doyle, et al.. (2009). Mutant p53 Drives Invasion by Promoting Integrin Recycling. Cell. 139(7). 1327–1341. 641 indexed citations breakdown →

Yang, Yili, Jirouta Kitagaki, Ren‐Ming Dai, et al.. (2007). Inhibitors of Ubiquitin-Activating Enzyme (E1), a New Class of Potential Cancer Therapeutics. Cancer Research. 67(19). 9472–9481. 372 indexed citations

Wilson, J. M., Graham Henderson, Fiona Black, et al.. (2006). Synthesis of 5-deazaflavin derivatives and their activation of p53 in cells. Bioorganic & Medicinal Chemistry. 15(1). 77–86. 34 indexed citations

Yang, Yili, Robert L. Ludwig, Jane P. Jensen, et al.. (2005). Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells. Cancer Cell. 7(6). 547–559. 263 indexed citations

Weber, Hans, et al.. (2005). HDM2 phosphorylation by MAPKAP kinase 2. Oncogene. 24(12). 1965–1972. 48 indexed citations

Lohrum, Marion, Robert L. Ludwig, Michael H.G. Kubbutat, Mary H. Hanlon, & Karen H. Vousden. (2003). Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell. 3(6). 577–587. 521 indexed citations breakdown →

10.

Ashcroft, Margaret, Robert L. Ludwig, Douglas Woods, et al.. (2002). Phosphorylation of HDM2 by Akt. Oncogene. 21(13). 1955–1962. 160 indexed citations

11.

Lohrum, Marion, Douglas Woods, Robert L. Ludwig, Éva Bálint, & Karen H. Vousden. (2001). C-Terminal Ubiquitination of p53 Contributes to Nuclear Export. Molecular and Cellular Biology. 21(24). 8521–8532. 195 indexed citations

12.

Fang, Shengyun, Jane P. Jensen, Robert L. Ludwig, Karen H. Vousden, & Allan M. Weissman. (2000). Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53. Journal of Biological Chemistry. 275(12). 8945–8951. 874 indexed citations breakdown →

13.

Ludwig, Robert L., et al.. (1998). Activation of p53 DNA binding activity by point mutation. Oncogene. 16(24). 3123–3131. 11 indexed citations

14.

Kubbutat, Michael H.G., Robert L. Ludwig, Margaret Ashcroft, & Karen H. Vousden. (1998). Regulation of Mdm2-Directed Degradation by the C Terminus of p53. Molecular and Cellular Biology. 18(10). 5690–5698. 166 indexed citations

15.

Ludwig, Robert L., Stewart Bates, & Karen H. Vousden. (1996). Differential Activation of Target Cellular Promoters by p53 Mutants with Impaired Apoptotic Function. Molecular and Cellular Biology. 16(9). 4952–4960. 228 indexed citations

16.

Gonos, Efstathios S., Jorge S. Burns, Susan C. Barnett, et al.. (1996). Rat Embryo Fibroblasts Immortalized with Simian Virus 40 Large T Antigen Undergo Senescence upon Its Inactivation. Molecular and Cellular Biology. 16(9). 5127–5138. 35 indexed citations

17.

Crook, Tim, et al.. (1996). Sensitivity of p53 Lysine Mutants to Ubiquitin-Directed Degradation Targeted by Human Papillomavirus E6. Virology. 217(1). 285–292. 34 indexed citations

18.

May, Gerald R., et al.. (1988). Clinical Imaging of the Pancreas. Journal of Clinical Gastroenterology. 10(2). 236–236. 2 indexed citations

19.

Obberghen‐Schilling, Ellen Van, Paturu Kondaiah, Robert L. Ludwig, Michael B. Sporn, & Carl C. Baker. (1987). Complementary Deoxyribonucleic Acid Cloning of Bovine Transforming Growth Factor-β1. Molecular Endocrinology. 1(10). 693–698. 64 indexed citations

20.

Smith, J. M., Robert L. Ludwig, & Ralph C. Marcove. (1987). Sacrococcygeal chordoma. Skeletal Radiology. 16(1). 37–44. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact